Cabaletta Bio Inc (CABA)
12.34
-0.28
(-2.22%)
USD |
NASDAQ |
May 17, 16:00
12.67
+0.33
(+2.67%)
After-Hours: 20:00
Cabaletta Bio Market Cap: 596.21M for May 17, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 17, 2024 | 596.21M |
| May 16, 2024 | 609.25M |
| May 15, 2024 | 612.63M |
| May 14, 2024 | 542.15M |
| May 13, 2024 | 543.59M |
| May 10, 2024 | 543.59M |
| May 09, 2024 | 589.60M |
| May 08, 2024 | 582.85M |
| May 07, 2024 | 614.69M |
| May 06, 2024 | 620.48M |
| May 03, 2024 | 597.81M |
| May 02, 2024 | 607.94M |
| May 01, 2024 | 598.77M |
| April 30, 2024 | 513.61M |
| April 29, 2024 | 505.65M |
| April 26, 2024 | 531.22M |
| April 25, 2024 | 587.67M |
| April 24, 2024 | 625.31M |
| April 23, 2024 | 642.68M |
| April 22, 2024 | 642.68M |
| April 19, 2024 | 643.64M |
| April 18, 2024 | 674.04M |
| April 17, 2024 | 730.97M |
| April 16, 2024 | 785.98M |
| April 15, 2024 | 780.67M |
| Date | Value |
|---|---|
| April 12, 2024 | 821.68M |
| April 11, 2024 | 864.14M |
| April 10, 2024 | 861.73M |
| April 09, 2024 | 908.05M |
| April 08, 2024 | 870.41M |
| April 05, 2024 | 819.27M |
| April 04, 2024 | 777.29M |
| April 03, 2024 | 769.47M |
| April 02, 2024 | 771.81M |
| April 01, 2024 | 787.26M |
| March 28, 2024 | 823.00M |
| March 27, 2024 | 827.34M |
| March 26, 2024 | 818.18M |
| March 25, 2024 | 809.98M |
| March 22, 2024 | 836.99M |
| March 21, 2024 | 846.16M |
| March 20, 2024 | 874.14M |
| March 19, 2024 | 868.35M |
| March 18, 2024 | 867.38M |
| March 15, 2024 | 904.05M |
| March 14, 2024 | 879.34M |
| March 13, 2024 | 938.71M |
| March 12, 2024 | 960.51M |
| March 11, 2024 | 945.20M |
| March 08, 2024 | 1.042B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
18.26M
Minimum
Sep 23 2022
1.177B
Maximum
Feb 08 2024
322.75M
Average
274.96M
Median
Market Cap Benchmarks
| Editas Medicine Inc | 462.18M |
| ACADIA Pharmaceuticals Inc | 2.444B |
| Alnylam Pharmaceuticals Inc | 18.90B |
| Regeneron Pharmaceuticals Inc | 108.23B |
| Vertex Pharmaceuticals Inc | 114.89B |
Market Cap Related Metrics
| Price to Book Value | 2.689 |
| Price | 12.34 |
| Earnings Yield | -13.93% |